Hybridoma Discovery
At Immunovive, we specialize in custom hybridoma development to support your monoclonal antibody discovery and production needs. Our end-to-end service combines decades of immunology expertise with rigorous quality control to deliver high-affinity, target-specific antibodies tailored to your research or therapeutic goals.
Service Overview
Antigen Design & Preparation: We begin by optimizing your antigen—whether peptide, protein, or cell-based—to ensure a strong and specific immune response.
Immunization Protocols: Using proven immunization strategies in mice or rats, we elicit robust B-cell activation for high-yield antibody production.
Cell Fusion & Clone Selection: Spleen cells from immunized animals are fused with myeloma cells to generate hybridomas. We screen and isolate clones producing antibodies with desired specificity and affinity.
Characterization & Validation: Each monoclonal antibody is rigorously tested for specificity, isotype, affinity, and cross-reactivity using ELISA, BLI, flow cytometry, or other relevant assays.
Cryopreservation & Delivery: Final hybridoma lines are cryopreserved for long-term storage and shipped according to your specifications.
Why Choose Us?
Customizable protocols to fit your target and application
High-throughput screening for rapid clone identification
Scalable production for research, diagnostic, or preclinical use
Confidential and IP-secure processes to protect your innovation
Whether you're developing antibodies for therapeutic screening, diagnostic assays, or basic research, our hybridoma production platform ensures precision, reliability, and scientific excellence at every step.